Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Capella Scientia Development Study

Capella Scientia (SCDX) Development Study

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study involves collecting biometry and aberration data using the next generation biometer, Unity DX.

Who May Be Eligible (Plain English)

Who May Qualify: - Able to understand and sign an IRB/IEC approved consent form; - Willing and able to attend study visit(s) as required by the protocol; - Consenting age at the jurisdiction of study site; - Other group-specific, protocol required inclusion criteria may apply. Who Should NOT Join This Trial: - Women of child-bearing potential; - Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus); - Unclear optical media preventing data capture from all devices in the study; - Contraindicated for pupil dilation (e.g., narrow angles, allergies) per investigator's clinical judgment; - Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study; - Other group-specific, protocol required exclusion criteria may apply. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Able to understand and sign an IRB/IEC approved consent form; * Willing and able to attend study visit(s) as required by the protocol; * Consenting age at the jurisdiction of study site; * Other group-specific, protocol required inclusion criteria may apply. Exclusion Criteria: * Women of child-bearing potential; * Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus); * Unclear optical media preventing data capture from all devices in the study; * Contraindicated for pupil dilation (e.g., narrow angles, allergies) per investigator's clinical judgment; * Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study; * Other group-specific, protocol required exclusion criteria may apply.

Treatments Being Tested

DEVICE

Unity DX and SMARTCataract DX (SCDX) Biometer

Unity DX is a CE-marked, noninvasive, noncontact instrument that generates a 3D model of the eye using hyper parallel optical coherence tomography (HP OCT), aberrometry, and topography. The current version of SCDX software will be used in this study.

DEVICE

IOLMaster 700 Biometer

The IOLMaster 700 Biometer is a CE-marked, noninvasive, noncontact instrument that captures optical biometry. Data will be collected using standard clinical assessments.

DEVICE

Argos with Alcon Image Guidance Biometer

The Argos with Alcon Image Guidance biometer is a CE-marked, noninvasive, noncontact instrument that will capture optical biometry. Data will be collected using standard clinical assessments.

Locations (4)

Narayana Nethralaya
Bangalore, India
Asian Eye Institute
Makati City, Philippines
Clinica Novovision - Clinica Madrid
Madrid, Spain
Clinica Rementeria
Madrid, Spain